7-4784347-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014855.3(AP5Z1):c.766G>A(p.Glu256Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 1,597,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP5Z1 | NM_014855.3 | c.766G>A | p.Glu256Lys | missense_variant | 6/17 | ENST00000649063.2 | NP_055670.1 | |
AP5Z1 | NM_001364858.1 | c.298G>A | p.Glu100Lys | missense_variant | 5/16 | NP_001351787.1 | ||
AP5Z1 | XM_047421098.1 | c.430G>A | p.Glu144Lys | missense_variant | 4/15 | XP_047277054.1 | ||
AP5Z1 | NR_157345.1 | n.859G>A | non_coding_transcript_exon_variant | 6/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP5Z1 | ENST00000649063.2 | c.766G>A | p.Glu256Lys | missense_variant | 6/17 | NM_014855.3 | ENSP00000497815 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152020Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000232 AC: 5AN: 215512Hom.: 0 AF XY: 0.00000843 AC XY: 1AN XY: 118566
GnomAD4 exome AF: 0.0000256 AC: 37AN: 1445518Hom.: 0 Cov.: 42 AF XY: 0.0000223 AC XY: 16AN XY: 717902
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152020Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74244
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 48 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2021 | This sequence change replaces glutamic acid with lysine at codon 256 of the AP5Z1 protein (p.Glu256Lys). The glutamic acid residue is moderately conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at